Eosinophilic Asthma Latest Advances

Factors Associated With Systemic Corticosteroid Use in Patients With Asthma: A Real-Life Study.

Journal: Cureus

Published: November 22, 2025

Interesting Case of Mesocardia: A Rare Cardiac Positional Anomaly.

Journal: Respirology case reports

Published: November 20, 2025

Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Journal: Current opinion in allergy and clinical immunology

Published: October 29, 2025

Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: October 02, 2025

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Journal: Journal of clinical medicine

Published: September 22, 2025

Cytokine and Metabolomic Signatures of Mepolizumab Response Across Upper and Lower Airway Compartments in Severe Eosinophilic Asthma: An Exploratory Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 15, 2025

Increasing the dosing interval of dupilumab in patients with severe asthma and chronic rhinosinusitis with nasal polyps.

Journal: European annals of allergy and clinical immunology

Published: September 15, 2025

Effects of Eosinophilopoietins and C-C Chemokines on Chemotaxis, Adhesion, and ROS Production of Blood Eosinophil Subtypes in Asthma Patients.

Journal: Journal of inflammation research

Published: September 13, 2025

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study.

Journal: Frontiers in immunology

Published: September 10, 2025

Oscillometry-defined small airway dysfunction in steroid-naïve adult bronchial asthma: association with eosinophilic and non-eosinophilic phenotypes.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: September 05, 2025

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment.

Journal: International journal of molecular sciences

Published: September 02, 2025

Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review.

Journal: Journal of clinical medicine

Published: August 30, 2025

Filters

Factors Associated With Systemic Corticosteroid Use in Patients With Asthma: A Real-Life Study.

Factors Associated With Systemic Corticosteroid Use in Patients With Asthma: A Real-Life Study.

Interesting Case of Mesocardia: A Rare Cardiac Positional Anomaly.

Interesting Case of Mesocardia: A Rare Cardiac Positional Anomaly.

Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab

Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Cytokine and Metabolomic Signatures of Mepolizumab Response Across Upper and Lower Airway Compartments in Severe Eosinophilic Asthma: An Exploratory Analysis.

Cytokine and Metabolomic Signatures of Mepolizumab Response Across Upper and Lower Airway Compartments in Severe Eosinophilic Asthma: An Exploratory Analysis.

Increasing the dosing interval of dupilumab in patients with severe asthma and chronic rhinosinusitis with nasal polyps.

Increasing the dosing interval of dupilumab in patients with severe asthma and chronic rhinosinusitis with nasal polyps.

Effects of Eosinophilopoietins and C-C Chemokines on Chemotaxis, Adhesion, and ROS Production of Blood Eosinophil Subtypes in Asthma Patients.

Effects of Eosinophilopoietins and C-C Chemokines on Chemotaxis, Adhesion, and ROS Production of Blood Eosinophil Subtypes in Asthma Patients.

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study.

Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study.

Oscillometry-defined small airway dysfunction in steroid-naïve adult bronchial asthma: association with eosinophilic and non-eosinophilic phenotypes.

Oscillometry-defined small airway dysfunction in steroid-naïve adult bronchial asthma: association with eosinophilic and non-eosinophilic phenotypes.

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment.

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment.

Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review.

Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review.